Back to Search
Start Over
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies:literature review and ESUR Contrast Media Safety Committee guidelines
- Source :
- Stacul , F , Bertolotto , M , Thomsen , H S , Pozzato , G , Ugolini , D , Bellin , M-F , Bongartz , G , Clement , O , Heinz-Peer , G , van der Molen , A , Reimer , P , Webb , J A W & ESUR Contrast Media Safety Committee 2018 , ' Iodine-based contrast media, multiple myeloma and monoclonal gammopathies : literature review and ESUR Contrast Media Safety Committee guidelines ' , European Radiology , vol. 28 , no. 2 , pp. 683-691 .
- Publication Year :
- 2018
-
Abstract
- OBJECTIVES: Many radiologists and clinicians still consider multiple myeloma (MM) and monoclonal gammopathies (MG) a contraindication for using iodine-based contrast media. The ESUR Contrast Media Safety Committee performed a systematic review of the incidence of post-contrast acute kidney injury (PC-AKI) in these patients.METHODS: A systematic search in Medline and Scopus databases was performed for renal function deterioration studies in patients with MM or MG following administration of iodine-based contrast media. Data collection and analysis were performed according to the PRISMA statement 2009. Eligibility criteria and methods of analysis were specified in advance. Cohort and case-control studies reporting changes in renal function were included.RESULTS: Thirteen studies were selected that reported 824 iodine-based contrast medium administrations in 642 patients with MM or MG, in which 12 unconfounded cases of PC-AKI were found (1.6 %). The majority of patients had intravenous urography with high osmolality ionic contrast media after preparatory dehydration and purgation.CONCLUSIONS: MM and MG alone are not risk factors for PC-AKI. However, the risk of PC-AKI may become significant in dehydrated patients with impaired renal function. Hypercalcaemia may increase the risk of kidney damage, and should be corrected before contrast medium administration. Assessment for Bence-Jones proteinuria is not necessary.KEY POINTS: • Monoclonal gammopathies including multiple myeloma are a large spectrum of disorders. • In monoclonal gammopathy with normal renal function, PC-AKI risk is not increased. • Renal function is often reduced in myeloma, increasing the risk of PC-AKI. • Correction of hypercalcaemia is necessary in myeloma before iodine-based contrast medium administration. • Bence-Jones proteinuria assessment in myeloma is unnecessary before iodine-based contrast medium administration.
Details
- Database :
- OAIster
- Journal :
- Stacul , F , Bertolotto , M , Thomsen , H S , Pozzato , G , Ugolini , D , Bellin , M-F , Bongartz , G , Clement , O , Heinz-Peer , G , van der Molen , A , Reimer , P , Webb , J A W & ESUR Contrast Media Safety Committee 2018 , ' Iodine-based contrast media, multiple myeloma and monoclonal gammopathies : literature review and ESUR Contrast Media Safety Committee guidelines ' , European Radiology , vol. 28 , no. 2 , pp. 683-691 .
- Notes :
- application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1322702199
- Document Type :
- Electronic Resource